- Filed
- Aug 12, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Aug 9, 2024 | 414.45M sh |
| Cash And Equivalents | Q2 2024 · Jun 30, 2024 | $194.39K |
| Cash And Equivalents | Q2 2024 · Dec 31, 2023 | $699.35K |
| Current Liabilities | Q2 2024 · Jun 30, 2024 | $1.41M |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $1.62M |
| Total Liabilities | Q2 2024 · Jun 30, 2024 | $1.63M |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $1.86M |
| Current Assets | Q2 2024 · Jun 30, 2024 | $1.7M |
| Current Assets | Q2 2024 · Dec 31, 2023 | $1.66M |
| Total Assets | Q2 2024 · Jun 30, 2024 | $2.07M |
| Total Assets | Q2 2024 · Dec 31, 2023 | $2.09M |
| Shares Diluted | Q2 2024 · Jun 30, 2023 | 414.45M sh |
| Shares Diluted | Q2 2024 · Jun 30, 2023 | 414.45M sh |
| Capex | Q2 2024 · Jun 30, 2023 | $8.16K |
| Operating Cash Flow | Q2 2024 · Jun 30, 2023 | −$323.85K |
| Stockholders Equity | Q2 2024 · Jun 30, 2023 | $317.92K |
| Stockholders Equity | Q2 2024 · Mar 31, 2023 | $444.18K |
| Stockholders Equity | Q2 2024 · Dec 31, 2022 | $452.59K |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | $0.00 |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | $0.00 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | $0.00 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | $0.00 |
| Net Income | Q2 2024 · Jun 30, 2023 | −$126.27K |
| Net Income | Q2 2024 · Jun 30, 2023 | −$134.68K |
| Net Income | Q2 2024 · Mar 31, 2023 | −$8.41K |
| Operating Income | Q2 2024 · Jun 30, 2023 | −$127.66K |
| Operating Income | Q2 2024 · Jun 30, 2023 | −$129.15K |
| Gross Profit | Q2 2024 · Jun 30, 2023 | $475.54K |
| Gross Profit | Q2 2024 · Jun 30, 2023 | $978.79K |
| Cost Of Revenue restated | Q2 2024 · Jun 30, 2023 | $125.91K |
| Cost Of Revenue restated | Q2 2024 · Jun 30, 2023 | $254.91K |